The panelist discusses Vowst, an FDA-approved live microbiota therapeutic that works by introducing healthy donor-derived gut ...

Clostridioides difficile is a type of bacteria that often affects people who have been taking antibiotics, GST Micro LLC ...

The panelist discusses Rebyota, a treatment approved by the FDA for preventing recurrent Clostridioides difficile infections in adults who have completed antibiotic treatment for recurrent C difficile ...

Pharmaceuticals announced updates on Phase 3 Readiness for Ibezapolstat in C. difficile Infection based on recent FDA and EMA ...

The product is based on purified Firmicutes bacterial spores delivered in an oral capsule that is designed to encourage the regrowth of healthy bacteria after antibiotic treatment for C.

The Company today announced updates on Phase 3 Readiness for Ibezapolstat in C. difficile Infection based on recent FDA and EMA Communications ... s ability to achieve Clinical Cure of CDI as measured ...

Following the previously announced successful End of Phase 2 Meeting achieving agreement with FDA on non-clinical and clinical Phase 3-readiness, Acurx has now also received written positive feedback ...

A live biotherapeutic, SER-155 secured FDA fast track status in December 2023. SER-155 also supports the decrease of ...

According to the National Institute of Mental Health (NIMH), more than one in five adults (about 20%) in the United States has a mental health condition. Treatments for mental health conditions are ...

The treatment with the most research support for ... quality of practice (e.g., how well they engage in exposure); (c) and ritual prevention (e.g., resisting urges to engage in compulsions between ...

Check out our guide for free and lower cost STD testing locations in all 50 states and Washington, D.C. You may find free STI testing and treatment at your local health department or community ...